Proteomics takes diabetes marker to America

Perth biotechnology group Proteomics International Laboratories has reached an agreement to exclusively licence its PromarkerD test for diabetes to Sonic Healthcare USA. An estimated 32 million people or 11 percent of the American population live with diabetes, with PromarkerD the only test available that is able to identify their risk of developing diabetic kidney disease.…

Manufacturing news briefs – stories you might have missed

First commercial space launch blasts off from Arnhem Land Equatorial Launch Australia (ELA) owner of the Arnhem Space Centre (ASC) on the Gove Peninsula in Australia’s Northern Territory last night successfully completed Australia’s first commercial space launch with NASA (rocket, pictured). The historic launch was NASA’s first from a fully commercial spaceport and is the…

Plant-based patties, lab-grown meat and insects: how the protein industry is innovating to meet demand

By Katherine Wynn, CSIRO and Michelle Colgrave, CSIRO As demand for alternative protein sources grows, Australians are increasingly looking for options that are healthy, sustainable and ethically made. At CSIRO, we have produced a “protein roadmap” to guide investments in a diverse range of new products and ingredients. We believe plant-based patties, lab-made meat and…

Manufacturing news briefs – stories you might have missed

Proteomics International enters UK market. Perth biotechnology group Proteomics International Laboratories has secured United Kingdom distribution for its PromarkerD test system to predict the onset of diabetic kidney disease. Apacor Ltd will become the exclusive distributor for PromarkerD covering an estimated 4.8 million people who live with diabetes, making them vulnerable to kidney disease. The…

Grants totalling $450,000 awarded to five WA medtech companies

Five Western Australian companies have been awarded a total of $450,000 in grants through the WA Medical Technology and Pharmaceutical (MTP) Manufacturing Voucher Program. The program aims to accelerate the development and manufacturing of medical technology and pharmaceutical products in the state. “We have an enormous opportunity to capitalise on home-grown medical technology to help…